Immuno-PCR method for the detection of a biomolecule in a test sample

• US 20050239108A1
• Filed: 02/23/2005
• Published: 10/27/2005
• Est. Priority Date: 02/23/2004
• Status: Abandoned Application

• Current Assignee: Seracare Life Sciences, Inc., University of Maryland Baltimore County (University of Maryland)
• Original Assignee: University of Maryland Baltimore County (University of Maryland)
• Inventors: Constantine, Niel T., Highsmith, William Jr., Barletta, Janet M., Tai, Chang-Chih, Edelman, Daniel, Ji, Jay, Manak, Mark
• Application Number:
  US11/062,809
• Publication Number:
  US 20050239108A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: G01N 2458/10 Oligonucleotides as tagging agents for labelling antibodies
• CPC Class Codes: G01N 33/54306 Solid-phase reaction mechanisms

Abstract

The invention relates to methods and kits for detecting and/or monitoring biological molecules in a test sample. For example, the invention relates to methods and kits for detecting and/or monitoring HIV p24 antigen in human body fluid, biological toxins such as ricin or botulism in an environmental or biological sample, and prion protein from human, deer or bovine, such as PrP^SC, in a biological sample. The antigen detection signal is boosted by amplification of a polynucleotide linked to a detector molecule using methods for nucleic acid amplification technology.

Claims

1. A method for detecting a biomolecule in a sample, said method comprising:

(a) incubating a sample with a capture molecule that specifically binds a selected biomolecule under conditions such that said selected biomolecule in said sample is bound by said capture molecule, wherein said capture molecule comprises a molecule that specifically binds to said biomolecule and said capture molecule is attached to a solid support,

(b) incubating the resulting product of step (a) with a detector molecule that specifically binds said selected biomolecule under conditions such that said selected biomolecule bound by said capture molecule is also bound by said detector molecule, wherein said detector molecule comprises (i) a molecule that specifically binds to said biomolecule and (ii) at least one biotin moiety,

(c) incubating the resulting product of step (b) with a linker molecule under conditions such that said linker molecule binds to a biotin moiety of said detector molecule, wherein said linker molecule comprises at least one avidin moiety or at least one streptavidin moiety, or a combination thereof,

(d) incubating the resulting product of step (c) with an amplification reagent under conditions such that said amplification reagent binds to said linker molecule, wherein said amplification reagent comprises (i) a polynucleotide molecule and (ii) at least one biotin moiety,

(e) performing polymerase chain reaction (PCR) on the resulting product of step (d) in the presence of a signal molecule, and

(f) detecting a PCR product produced in step (e) by detecting a signal from the signal molecule, thereby detecting a biomolecule in said sample.

8. The method of any one of claims 1-4, wherein said capture molecule is attached to the solid support by an attachment means selected from the group consisting of adsorption, covalent linkage, avidin-biotin linkage, streptavidin-biotin linkage, heterobifunctional cross-linker, Protein A linkage and Protein G linkage.

9. The method of claim 8, wherein said adsorption is hydrophilic adsorption.

10. The method of claim 8, wherein the solid support is derivatized with avidin or streptavidin, and the capture molecule comprises at least one biotin moiety.

11. The method of claim 8, wherein the solid support is derivatized with biotin, and the capture molecule comprises at least one avidin moiety or at least one streptavidin moiety.

12. The method of claim 8, wherein the heterobifunctional cross-linker is selected from the group consisting of maleic anhydride, 3-aminopropyl trimethoxysilane (APS), N-5 azido, 2-nitrobenzoyaloxysuccinimide (ANB-NOS) and mercaptosilane.

13. The method of claim 8, wherein said capture molecule is attached to the solid support by a portion of the capture molecule selected from the group consisting of a lysine residue, an arginine residue, a thiol group and a carbohydrate residue.

14. The method of claim 13, wherein said capture molecule is an antibody and the thiol group is a thiol group of the antibody hinge region.

15. The method of any one of claims 1-4, further comprising blocking or reducing non-specific reactivity by adding a blocking reagent.

16. The method of claim 15, wherein the blocking reagent is selected from the group consisting of a non-ionic surfactant, heparin, a chelating agent, EDTA, BSA, serum, a cell lysate, and non-fat dry milk.

17. The method of claim 15, wherein the non-ionic surfactant is Tween-20 or NP 40.

18. The method of any one of claims 1-4, wherein said biomolecule is a polypeptide or a peptide.

19. The method of claim 18, wherein said polypeptide is a biological toxin selected from the group consisting of botulinum toxin and ricin.

20. The method of claim 18, wherein said polypeptide is a prion.

21. The method of claim 20, wherein said prion is human PrP^SC, deer PrP^SC, or bovine PrP^SC.

22. The method of any one of claims 1-4, wherein said sample is an environmental sample selected from the group consisting of water, soil, air and a biological material.

23. The method of any one of claims 1-4, wherein said sample is a biological sample selected from the group of consisting of serum, plasma, saliva, whole blood, semen, urine, cerebrospinal fluid, neuronal tissue, sputum, nasal secretions and bronchial secretions.

24. The method of any one of claims 1-4, wherein the capture molecule and the portion of the detector molecule that specifically binds to the biomolecule are each independently a member selected from the group consisting of a monoclonal antibody, a polyclonal antibody, a phage derived antibody, an antibody fragment, a peptide, a ligand, a hapten, a nucleic acid, a nucleic acid aptamer, protein A, protein G, folate, a folate binding protein, plasminogen, a maleimide reactive group and a sulfhydryl reactive group.

25. The method of claim 24, wherein said capture molecule and the portion of the detector molecule that specifically binds to the biomolecule are both a monoclonal antibody or antibody fragment.

26. The method of any one of claims 1-4, wherein said solid support is a member selected from the group consisting of polystyrene, derivatized polystyrene, a membrane, a latex bead, a glass bead, a silica bead, a paramagnetic microsphere, a latex microsphere, and a microtiter well.

27. The method of claim 26, wherein said solid support is a microtiter well.

28. The method of claim 26, wherein said membrane is selected from the group consisting of a nitrocellulose membrane, a PVDF membrane and a nylon membrane.

29. The method of any one of claims 1-4, wherein said polynucleotide molecule is a DNA polynucleotide, a RNA polynucleotide or a peptide nucleic acid polynucleotide.

30. The method of claim 29, wherein said polynucleotide molecule is a DNA polynucleotide.

31. The method of claim 29, wherein said polynucleotide molecule is a DNA polynucleotide of at least 250 nucleotides.

32. The method of any one of claims 1-3, wherein at least about 10% of nucleotides of said polynucleotide molecule are biotinylated.

33. The method of any one of claims 1-4, wherein the signal molecule comprises an oligonucleotide molecule that specifically binds a product of the PCR, and wherein said oligonucleotide molecule has a fluorophore and a quencher dye bound thereto.

34. The method of any one of claims 1-4, wherein the step of performing PCR is conducted in the presence of an oligonucleotide primer that hybridizes with said polynucleotide molecule and primes said PCR.

35. The method of claim 33, wherein the fluorophore is selected from the group consisting of 6-carboxyfluorescein, Alexa, Cy5, Texas Red, TET, HEX, JOE, Cys-3, VIC, ROX, Rhodamine and FAM.

36. The method of claim 33, wherein the fluorophore is 6-carboxyfluorescein.

37. The method of claim 33, wherein the quencher dye is selected from the group consisting of 3′

-Black Hole Quencher dye, DABCL, TAMRA and QSY.

38. The method of claim 33, wherein the quencher dye is 3′

-Black Hole Quencher dye.

39. The method of any one of claims 1-4, wherein said detecting a PCR product by detecting a signal from the signal molecule is performed by detecting a fluorescent signal.

40. The method of any one of claims 1-4, wherein the step of performing PCR is repeated.

41. The method of any one of claims 1-4, wherein the step of performing PCR is repeated using a second primer.

42. The method of any one of claims 1-4, wherein about 300 fg or less of said biomolecule is detected in said sample.

43. The method of any one of claims 1-4, wherein about 0.7 ng/mL or less of said biomolecule is detectable in said sample.

44. The method of any one of claims 1-4, wherein about 0.1 ng/mL or less of said biomolecule is detectable in said sample.

45. The method of any one of claims 1-4, wherein about 1 pg/mL or less of said biomolecule is detectable in said sample.

46. The method of any one of claims 1-4, wherein about 0.01 pg/mL or less of said biomolecule is detectable in said sample.

2. A method for detecting a biomolecule in a sample, said method comprising:

(a) incubating a sample with a capture molecule that specifically binds a selected biomolecule under conditions such that said selected biomolecule in said sample is bound by said capture molecule, wherein said capture molecule comprises a molecule that specifically binds to said biomolecule and said capture molecule is attached to a solid support,

(b) incubating the resulting product of step (a) with a detector molecule that specifically binds said selected biomolecule under conditions such that said selected biomolecule bound by said capture molecule is also bound by said detector molecule, wherein said detector molecule comprises (i) a molecule that specifically binds to said biomolecule and (ii) at least one avidin moiety or at least one streptavidin moiety, or a combination thereof,

(c) incubating the resulting product of step (b) with an amplification reagent under conditions such that said amplification reagent binds to said avidin or said streptavidin, or both, of said detector molecule, wherein said amplification reagent comprises (i) a polynucleotide molecule and (ii) at least one biotin moiety,

(d) performing polymerase chain reaction (PCR) on the resulting product of step (c) in the presence of a signal molecule, and

(e) detecting a PCR product produced in step (d) by detecting a signal from the signal molecule, thereby detecting a biomolecule in said sample.

3. A method for detecting a biomolecule in a sample, said method comprising:

(A) incubating a sample with a capture molecule that specifically binds a selected biomolecule under conditions such that said selected biomolecule in said sample is bound by said capture molecule, wherein said capture molecule comprises a molecule that specifically binds to said biomolecule and said capture molecule is attached to a solid support,

(B) incubating the resulting product of step (A) with a detector-signal conjugate, said conjugate comprising;

(i) a detector molecule comprising (a) a molecule that specifically binds to said biomolecule and (b) at least one biotin moiety,

(ii) a linker molecule bound to a biotin moiety of said detector molecule, wherein said linker molecule comprises at least one avidin moiety or at least one streptavidin moiety, or a combination thereof,

(iii) an amplification reagent bound to an avidin moiety or a streptavidin moiety, or both, of said linker molecule, wherein said amplification reagent comprises (a) a polynucleotide molecule and (b) at least one biotin moiety,

(C) performing polymerase chain reaction (PCR) on the resulting product of step (B) in the presence of a signal molecule, and

(D) detecting a PCR product produced in step (C) by detecting a signal from the signal molecule, thereby detecting a biomolecule in a sample.

4. A method for detecting a biomolecule in a sample, said method comprising:

(a) incubating a sample with a capture molecule that specifically binds a selected biomolecule under conditions such that said selected biomolecule in said sample is bound by said capture molecule, wherein said capture molecule comprises a molecule that specifically binds to said biomolecule and said capture molecule is attached to a solid support,

(b) incubating the resulting product of step (a) with a detector molecule-amplification reagent conjugate, said conjugate comprising a detector molecule attached to an amplification reagent, wherein said detector molecule comprises a molecule that specifically binds to said biomolecule and wherein said amplification reagent comprises a polynucleotide molecule,

(c) performing polymerase chain reaction (PCR) on the resulting product of step (b) in the presence of a signal molecule, and

(d) detecting a PCR product produced in step (c) by detecting a signal from the signal molecule, thereby detecting a biomolecule in a sample.

5. The method of claim 4, wherein the detector molecule is covalently attached to the amplification reagent.

6. The method of claim 4, wherein the detector molecule is attached to the amplification reagent by a heterobifunctional reagent.

7. The method of claim 6, wherein the heterobifunctional reagent is carbodiimide EDC or a sulfhydryl reactive site.

47. A method for detecting bovine PrP^SC in a sample, said method comprising:

(a) incubating a sample with a capture molecule that specifically binds bovine PrP^SC under conditions such that bovine PrP^SC in said sample is bound by said capture molecule, wherein said capture molecule comprises a molecule that specifically binds to bovine PrP^SC and said capture molecule is attached to a solid support,

(b) incubating the resulting product of step (a) with a detector molecule that specifically binds bovine PrP^SC under conditions such that bovine PrP^SC bound by said capture molecule is also bound by said detector molecule, wherein said detector molecule comprises (i) a molecule that specifically binds to bovine PrP^SC and (ii) at least one biotin moiety,

(c) incubating the resulting product of step (b) with a linker molecule under conditions such that said linker molecule binds to a biotin moiety of said detector molecule, wherein said linker molecule comprises at least one avidin moiety or at least one streptavidin moiety, or a combination thereof,

(d) incubating the resulting product of step (c) with an amplification reagent under conditions such that said amplification reagent binds to said linker molecule, wherein said amplification reagent comprises (i) a polynucleotide molecule and (ii) at least one biotin moiety,

(e) performing polymerase chain reaction (PCR) on the resulting product of step (d) in the presence of a signal molecule, and

(f) detecting a PCR product produced in step (e) by detecting a signal from the signal molecule, thereby detecting bovine PrP^SC in said sample.

48. The method of claim 47, further comprising enriching said sample for bovine PrP^SC prior to incubation of the sample with a capture molecule in (a).

49. The method of claim 48, wherein said enriching is performed by addition of ribolyser to said sample to release bovine PrP^SC in said sample.

50. The method of claim 48, wherein said enriching is performed by centrifugation or filtration of said sample.

51. The method of claim 48, wherein said enriching is performed by digestion of said sample with Protease K.

52. The method of claim 47, wherein said sample is a biological sample selected from the group of consisting of serum, plasma, saliva, whole blood, semen, urine, cerebrospinal fluid, neuronal tissue, sputum, nasal secretions and bronchial secretions.

53. The method of claim 47, wherein said solid support is a microtiter well.

54. The method of claim 47, wherein said polynucleotide molecule is a DNA polynucleotide.

55. The method of claim 47, wherein said polynucleotide molecule is a DNA polynucleotide of at least 250 nucleotides.

56. The method of claim 47, wherein at least about 10% of nucleotides of said polynucleotide molecule are biotinylated.

57. The method of claim 47, wherein the step of performing PCR is conducted in the presence of an oligonucleotide primer that hybridizes with said polynucleotide molecule and primes said PCR.

58. The method of claim 47, wherein the signal molecule comprises an oligonucleotide molecule that specifically binds a product of the PCR, and wherein said oligonucleotide molecule has a fluorophore and a quencher dye bound thereto.

59. The method of claim 47, wherein the fluorophore is selected from the group consisting of 6-carboxyfluorescein, Alexa, Cy5, Texas Red, TET, HEX, JOE, Cys-3, VIC, ROX, Rhodamine and FAM.

60. The method of claim 47, wherein the fluorophore is 6-carboxyfluorescein.

61. The method of claim 47, wherein the quencher dye is selected from the group consisting of 3′

-Black Hole Quencher dye, DABCL, TAMRA and QSY.

62. The method of claim 47, wherein the quencher dye is 3′

-Black Hole Quencher dye.

63. The method of claim 47, wherein said detecting a PCR product by detecting a signal from the signal molecule is performed by detecting a fluorescent signal.

64. The method of claim 47, wherein the step of performing PCR is repeated.

65. The method of claim 47, wherein about 300 fg or less of said bovine PrP^SC is detected in said sample.

66. The method of claim 47, wherein about 0.7 ng/mL or less of said bovine PrP^SC is detectable in said sample.

67. The method of claim 47, wherein about 0.1 ng/mL or less of said bovine PrP^SC is detectable in said sample.

68. The method of claim 47, wherein about 1 pg/mL or less of said bovine PrP^SC is detectable in said sample.

69. The method of claim 47, wherein about 0.01 pg/mL or less of said bovine PrP^SC is detectable in said sample.

70. A kit comprising:

(a) a capture molecule attached to a solid support, wherein said capture molecule comprises a molecule that specifically binds to a pre-selected biomolecule,

(b) a detector molecule, wherein said detector molecule comprises (i) a molecule that specifically binds to said pre-selected biomolecule and (ii) at least one biotin moiety,

(c) an linker molecule, wherein said linker molecule comprises at least one avidin moiety or at least one streptavidin moiety, or a combination thereof,

(d) an amplification reagent, wherein said amplification reagent comprises (i) a polynucleotide molecule and (ii) at least one biotin moiety,

(e) an oligonucleotide primer that specifically binds to said polynucleotide molecule,

(f) a signal molecule comprising (i) an oligonucleotide molecule that specifically binds the polynucleotide molecule, (ii) a fluorophore and (iii) a quencher dye, and

(g) a set of standards, wherein said standards allow an approximation of concentration of said pre-selected biomolecule in a sample.

71. The kit of claim 70, wherein said capture molecule and said detector molecule are each independently a member selected from the group consisting of a monoclonal antibody, a polyclonal antibody, a phage derived antibody, an antibody fragment, a peptide, a ligand, a hapten, a nucleic acid, a nucleic acid aptamer, protein A, protein G, folate, a folate binding protein, plasminogen, a maleimide reactive group and a sulfhydryl reactive group.

72. The kit of claim 70, wherein said capture molecule and the portion of the detector molecule that specifically binds to the biomolecule are both a monoclonal antibody or antibody fragment.

73. The kit of claim 70, wherein said solid support is a member selected from the group consisting of polystyrene, derivatized polystyrene, a membrane, a latex bead, a glass bead, a silica bead, a paramagnetic microsphere, a latex microsphere, and a microtiter well.

74. The kit of claim 73, wherein said solid support is a microtiter well.

75. The method of claim 73, wherein said membrane is selected from the group consisting of a nitrocellulose membrane, a PVDF membrane and a nylon membrane.

76. The kit of claim 70, wherein said polynucleotide molecule is a DNA polynucleotide, a RNA polynucleotide or a peptide nucleic acid polynucleotide.

77. The kit of claim 70, wherein said polynucleotide molecule is a DNA polynucleotide.

78. The kit of claim 70, wherein said polynucleotide molecule is a DNA polynucleotide of at least 250 nucleotides.

79. The kit of claim 70, wherein at least about 10% of nucleotides of said polynucleotide molecule are biotinylated.

80. The kit of claim 70, where said pre-selected biomolecule is a prion selected from the group consisting of human PrP^SC, bovine PrP^SC, or deer PrP^SC.

81. The kit of claim 70, wherein the fluorophore is selected from the group consisting of 6-carboxyfluorescein, Alexa, Cy5, Texas Red, TET, HEX, JOE, Cys-3, VIC, ROX, Rhodamine and FAM.

82. The kit of claim 70, wherein the fluorophore is 6-carboxyfluorescein.

83. The kit of claim 70, wherein the quencher dye is selected from the group consisting of 3′

-Black Hole Quencher dye, DABCL, TAMRA and QSY.

84. The kit of claim 70, wherein the quencher dye is 3′

-Black Hole Quencher dye.

85. The kit of claim 70, wherein said set of standards allows an approximation of concentration of said pre-selected biomolecule in said sample at a concentration of less than about 0.7 ng/mL.

86. The kit of claim 70, wherein said set of standards allows an approximation of concentration of said pre-selected biomolecule in said sample at a concentration of less than about 0.1 ng/mL.

87. The kit of claim 70, wherein said set of standards allows an approximation of concentration of said pre-selected biomolecule in said sample at a concentration of less than about 1 pg/mL.

88. The kit of claim 70, wherein said set of standards allows an approximation of concentration of said pre-selected biomolecule in said sample at a concentration of less than about 0.01 pg/mL.

89. A kit comprising:

(a) a first capture molecule attached to a solid support, wherein said first capture molecule comprises a molecule that specifically binds to a pre-selected biomolecule,

(b) a second capture molecule attached to said solid support, wherein said second capture molecule comprises a molecule that specifically binds to an internal control molecule,

(c) an internal control molecule,

(d) a first detector molecule-amplification reagent conjugate, said conjugate comprising a first detector molecule attached to a first polynucleotide molecule, wherein said first detector molecule comprises a molecule that specifically binds to said pre-selected biomolecule,

(e) a second detector molecule-amplification reagent conjugate, said conjugate comprising a second detector molecule attached to a second polynucleotide molecule, wherein said second detector molecule comprises a molecule that specifically binds to said internal control molecule, and wherein said second polynucleotide molecule is different from said first polynucleotide molecule,

(f) a first oligonucleotide primer that specifically binds to said first polynucleotide molecule,

(g) a second oligonucleotide primer that specifically binds to said second polynucleotide molecule,

(h) a first signal molecule comprising (i) an oligonucleotide molecule that specifically binds the first polynucleotide molecule, (ii) a first fluorophore and (iii) a quencher dye,

(i) a second signal molecule comprising (i) an oligonucleotide molecule that specifically binds the second polynucleotide molecule, (ii) a second fluorophore that can be distinguish from said first fluorophore and (iii) a quencher dye,

(j) a first set of standards, wherein said first set of standards allows an approximation of concentration of said pre-selected biomolecule in a sample, and

(k) a second set of standards, wherein said second set of standards allows an approximation of concentration of said internal control molecule in a sample.